Français
Movember
Prostate Cancer Canada Network
Our Team
Board of Directors
Halifax/ Atlantic Region
Atlantic Region Launch
Halifax FDWR 2011
August 2011
September 2011
October 2011
Corp. Supporters
Careers at PCC
Privacy Policy
Ethics & Accountability
Testimonials
Where Does Your Dollar Go?
About the Prostate
Early Detection Guidelines
Prevention
Non-Cancerous Prostate Conditions
PSA
Prostate Cancer
What is Cancer?
What is Prostate Cancer?
Prostate Cancer Disease States
PCA3 Test
Prostate Cancer Facts
Statistics
Glossary
Resources
Treatment
Experimental and Alternative Therapies
P.C. Assessment Tools
Science Behind PCATs
Disclaimer
Risk Assessment Quiz
Risk Factor
Age
Diet
Environmental Factors
Family History
Ethnicity / Nationality
Weight
A History of Success
Research Success Stories
Pilot Grant Program
Pilot Grant FAQs
Grant Application Guidelines
Copyright & Trademark Notice
Research Grants From Previous Years
Apply for a Pilot Grant
Request for Applications
Clinician Scientist Award
Clinician Scientist Awards From Previous Years
Clinician-Scientist Award Application
Clinician-Scientist Award Guidelines
2012 Request for Applications: Clinician-Scientist Program
Progress and Final Report
Scientific Medical Community
SMAC Sign In
News Articles
PC Awareness Month
Prostate Cancer News
It's Our Time
Foundation Publications
News Releases
PSAs
The Faces of Prostate Cancer
Events
Movember
Father's Day Walk/Run
PCCN Conference
Tied Together
Wake Up Call Breakfast
Community Events
How to Support Us
Host an Information Session
Monthly Giving Program
Sponsor an Event
Naming a Research Grant
Volunteer
Advocacy
Campaign to Control Cancer
Shop PCC
Purchase Our Merchandise
GIVE NOW
Ways to Donate
Planned Giving
Monthly Giving Program
Donate by Phone, Mail or Fax
Gifts of Publicly Traded Securities
Charity Car Donation Program
Where Does Your Dollar Go?
Prostate Cancer
What is Cancer?
What is Prostate Cancer?
Prostate Cancer Disease States
PCA3 Test
Prostate Cancer Facts
Statistics
Glossary
Resources
Treatment
Experimental and Alternative Therapies
For more information visit
www.movember.com
In The News
PSA Fitness (Power, Strength & Agility)
HALIFAX, N.S., January 16, 2012/CNW/ Prostate Cancer Canada Atlantic is proud to announce the launch of PSA Fitness (Power, Strength & Agility), a free nine week exercise program for men who have been diagnosed with prostate cancer. PSA Fitness, resistance training and yoga, is an important patient-centered therapy for prostate cancer survivors in Halifax.
TELUS donation to support Prostate Cancer Canada
Toronto, ON- January 13, 2012- On January 10th, Prostate Cancer Canada received a generous donation of $100,000 from TELUS at the launch of the TIEd Together exhibition. TELUS’ donation was made possible through the Canadian Football League Grey Cup cause marketing campaign. The donation will support Prostate Cancer Canada’s ongoing efforts to eliminate the disease through research, education, support and awareness.
Click For Information Archive
Statistics
25,500 men will be diagnosed with prostate cancer this year alone (2011).
4,100 men will die of the disease this year.*
During his lifetime, 1 in 7 men will be diagnosed with the disease.
Prostate cancer is the most common cancer to afflict Canadian men.
Rates of prostate cancer in men are comparable to rates of breast cancer in women.
The incidence of prostate cancer is increasing due to the aging of the population.
Over 90% of prostate cancer cases are curable if detected and treated in their earliest stages.
The disease is a far greater threat for those with a family history of prostate cancer.
Prostate cancer is turning up in men in their 40s.
Prostate cancer develops as a result of dietary, environmental and hereditary factors but more research is needed to identify its causes and prevent the disease.
The disease has no
symptoms in its earliest, most curable stage – so if you are 40 years old, we recommend you talk to your doctor about a prostate examination, including a digital rectal exam (DRE) and a prostate specific antigen (PSA) blood test.
Side effects – even of successful treatment – may include incontinence, impotence and changes in bowel habits.
Prostate cancer is often slow growing: in some patients, close monitoring may be sufficient treatment. Others, with more aggressive disease, warrant radical treatment with surgery or radiation. The latter treatments are sometimes combined with hormonal therapy.
Thought to be a potentially preventable cancer in many cases, but more research is needed and government support for this research is inadequate.
Incidence rates over time
Between 1989 and 1993 there was a sharp rise in the number of prostate cancer diagnoses. This sudden spike occurred after years of slow but steady increases in the incidence rate.
Experts believe that the increased number of diagnoses between 1989 and 1993 was not the result of new cases, but rather a result of previously undiagnosed cancer being caught by the PSA test.
Now that all the formerly undetected cancers have been diagnosed, the incidence rates have gone back to their slow and steady uphill climb.
Mortality rates
Evidence shows that between 1994 and 2003 fewer men died from the disease (2.7% average yearly decline). We don’t know if the lowered death rate is a result of early detection, better treatments or both.
* Source: Canadian Cancer Society Statistics 2011
Thanks for the follows! @RabyInstitute @THENUMBERUNEO @BBSupport @JackieManthorne @TELUS @ABJuniorCurling @PatientStories1 @healthfinder
Follow Us On Twitter
GIVE NOW!
Ethics and Accountability
About Prostate Cancer
Prostate Cancer News
Careers
Prostate Cancer Canada
2 Lombard Street, 3rd Floor, Toronto
Ontario M5C 1M1, Canada
info@prostatecancer.ca
Telephone: 416-441-2131
Toll-free: 1-888-255-0333
Fax: 416-441-2325
© 2011 - Prostate Cancer Canada - Charitable Registration Number: BN 89127 0944 RR0001
Design and Development
Inorbital